Efficacy and safety of tacrolimus combined with corticosteroids in patients with idiopathic membranous nephropathy: a systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of tacrolimus combined with corticosteroids in patients with idiopathic membranous nephropathy: a systematic review and meta-analysis of randomized controlled trials

Published:2022-03-11 Issue:10 Volume:54 Page:2555-2566
ISSN:1573-2584
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Tian Zhonghua^ORCID,Li Yuxia,Xie Yehong,Yang Yalin,Xu Jiangyan

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s11255-022-03169-6.pdf

Reference22 articles.

1. Glassock RJ (2010) The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis 56(1):157–167. https://doi.org/10.1053/j.ajkd.2010.01.008

2. Fervenza FC, Sethi S, Specks U (2008) Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol 3(3):905–919. https://doi.org/10.2215/CJN.04321007

3. Schieppati A, Mosconi L, Perna A et al (1993) Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 329(2):85–89. https://doi.org/10.1056/NEJM199307083290203

4. The KDIGO Work Group (2012) Chapter 7: Idiopathic membranous nephropathy. Kidney Int Suppl 2(2):186–197. https://doi.org/10.1038/kisup.2012.20

5. Faurschou M, Sorensen IJ, Mellemkjaer L et al (2008) Malignancies in Wegener’s granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol 35(1):100–105 (PMID: 17937462)

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel approach to induce early remission in high-risk primary membranous nephropathy;Nephrology Dialysis Transplantation;2024-06-17

2. Obinutuzumab in untreated primary membranous nephropathy: An observational case series;Nephrology;2024-06-03

3. Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy;Frontiers in Pharmacology;2022-05-26